Catherine owen adams succeeds steve davis as ceo of acadia pharmaceuticals

San diego--(business wire)--acadia pharmaceuticals inc. (nasdaq: acad) today announced that catherine owen adams has succeeded steve davis as chief executive officer (ceo) and joined the acadia board of directors. “we are excited to welcome catherine owen adams as the new ceo of acadia,” said stephen biggar, m.d., ph.d., chair of the board of directors. “catherine is a proven global leader with a distinguished record of accomplishment of driving growth and innovation in the pharmaceutical indus.
ACAD Ratings Summary
ACAD Quant Ranking